Inova Pharma & Life Science

Executive Summary

Inova Pharma & Life Science is a specialized Contract Development and Manufacturing Organization (CDMO) based in Dublin, Ireland, with a focus on small molecules and drug delivery technologies. Founded in 2015, the company offers comprehensive services including formulation development, analytical testing, scale-up, quality assurance, and regulatory support for value-added medicines, super-generics, and drug combinations. Agile and flexible, Inova serves global pharmaceutical and biotechnology companies, leveraging its expertise to accelerate product development and commercialization. The CDMO market is growing steadily, driven by increasing outsourcing trends, and Inova's niche in super-generics and drug combinations positions it well for near-term growth. The company's private status and lack of disclosed financials introduce uncertainty, but its established operations and client base in Ireland—a key hub for pharma—support a moderate conviction score of 65.

Upcoming Catalysts (preview)

• Q4 2026New facility expansion or capacity upgrade to meet growing demand60% success
• Q3 2026Strategic partnership or long-term manufacturing agreement with a major pharmaceutical company50% success
• Q2 2027Regulatory approval of a client's super-generic product developed by Inova55% success